Comparative efficacy and safety of anti-vascular endothelial growth factor regimens for neovascular age-related macular degeneration: systematic review and Bayesian network meta-analysis
Background: As a debilitating neurodegenerative disease, neovascular age-related macular degeneration (nAMD) accounts for more than 90% of severe visual loss or legal blindness among AMD patients. Anti-vascular endothelial growth factor (VEGF) had been applied widely in nAMD treatment. To date, deba...
Saved in:
Main Authors: | Lu Ye (Author), Zhao Jiaqi (Author), Wang Jianchao (Author), Feng Zhaohui (Author), Yao Liang (Author), Zhang Xiaohui (Author) |
---|---|
Format: | Book |
Published: |
SAGE Publishing,
2020-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Vascular Endothelial Growth Factor Antagonists: Promising Players in the Treatment of Neovascular Age-Related Macular Degeneration
by: Hussain RM, et al.
Published: (2021) -
Molecular Biomarkers of Neovascular Age-Related Macular Degeneration With Incomplete Response to Anti-Vascular Endothelial Growth Factor Treatment
by: Irmela Mantel, et al.
Published: (2020) -
Efficacy and Safety of Anti-Vascular Endothelial Growth Factor Monotherapies for Neovascular Age-Related Macular Degeneration: A Mixed Treatment Comparison
by: Yun Zhang, et al.
Published: (2021) -
Faricimab for the Treatment of Diabetic Macular Edema and Neovascular Age-Related Macular Degeneration
by: Lorenzo Ferro Desideri, et al.
Published: (2023) -
EFEMP1 Overexpression Contributes to Neovascularization in Age-Related Macular Degeneration
by: Lu Cheng, et al.
Published: (2021)